About Keith Sweeney
I am an anatomic and clinical pathologist with subspecialty training in surgical pathology, breast pathology, and molecular genetic pathology. Joining the staff in 2022, I work as an assistant professor in the Section of Breast Pathology and the Molecular Diagnostics Laboratory in the Division of Pathology and Laboratory Medicine at MD Anderson Cancer Center. I find fulfillment from the numerous clinical challenges, research opportunities, and educational responsibilities my role provides. I am involved in clinically oriented projects and serve as the pathology collaborator in multiple clinical trials, enjoying any opportunity to work collaboratively with the interdepartmental colleagues that make up our stellar multidisciplinary oncology teams. Regular didactic lectures and multihead microscope sessions provide me and our trainees the environment to learn together as our understanding of breast and molecular pathology continues to evolve. I look forward to applying that growing knowledge to further personalized cancer therapy in the years to come.
Assistant Professor, Department of Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
|2015||Albany Medical College (AMC), Albany, NY, USA, MD, Doctor of Medicine|
|2010||The University of Arizona (UA), Tucson, AZ, USA, BS, Bachelor of Science and Bachelor of Science in Health Sciences|
|2021-2022||Clinical Fellowship, Molecular Genetic Pathology Fellowship, The University of Texas MD Anderson Cancer Center (MDACC), Houston, NY|
|2020-2021||Clinical Fellowship, Selective Breast Pathology Fellowship, The University of Texas MD Anderson Cancer Center (MDACC), Houston, NY|
|2019-2020||Clinical Fellowship, Selective Surgical Pathology Fellowship, The University of Texas MD Anderson Cancer Center (MDACC), Houston, TX|
|2015-2019||Clinical Residency, Anatomic & Clinical Pathology Residency, Stony Brook University Hospital (SBUH), Stony Brook, NY|
|2020||Anatomic & Clinical Pathology, American Board of Pathology|
Co-Lead Molecular Genetic Pathology Fellow, Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - 2022
- Ai D, Sweeney K, Li X. Short review of malignant adenomyoepithelioma of the breast. Case Report. Human Pathology Report 27:300583, 2022.
- Sweeney KJ, Tetzlaff MT, Vega F, Gillenwater A, Zuo Z, Gross N, Nagarajan P, Wargo J, Nelson K, Prieto VG, Torres-Cabala CA, Curry JL. Tertiary lymphoid structures with overlapping histopathologic features of cutaneous marginal zone lymphoma during neoadjuvant cemiplimab therapy are associated with antitumor response. J Cutan Pathol 48(5):674-679, 2021. PMID: 33399228.
- Spallone A, Woroch L, Sweeney K, Seidman R, Marcos LA. The Burden of Neurocysticercosis at a Single New York Hospital. J Pathog 2020:8174240, 2020. PMID: 32802516.
- Cochrane E, Menzies A, Sweeney K, Burke W. Synchronous renal and para-aortic metastasis in a uterine serous carcinoma: A case review and clinical considerations. Gynecol Oncol Rep 28:12-14, 2019. PMID: 30740508.
- Farooq F, Zarrabi K, Sweeney K, Kim J, Bandovic J, Patel C, Choi M. Multiregion Comprehensive Genomic Profiling of a Gastric Mixed Neuroendocrine-Nonneuroendocrine Neoplasm with Trilineage Differentiation. J Gastric Cancer 18(2):200-207, 2018. PMID: 29984070.
- Zarrabi K, Choy T, Sweeney K, Desai V, Keresztes R. Paraneoplastic edematous dermatomyositis: A rare syndrome observed in a case of small cell lung cancer. Clin Pract 7(4):982, 2017. PMID: 29138685.
- Baer L, Rogers SC, Farrelly P, Tornos C, Sweeney K. The First Case of HER2+ Invasive Ductal Carcinoma Arising From a Breast Hamartoma and Literature Review. J Natl Med Assoc 109(1):55-59, 2017. PMID: 28259217.
- Zarrabi K, Sweeney K, Keresztes R. Imatinib mesylate-induced kidney injury in the treatment of a gastrointestinal stromal tumor. Case Reports in Internal Medicine 4(1):30-34, 2017.
- Califano D, Sweeney KJ, Le H, VanValkenburgh J, Yager E, O'Connor W, Kennedy JS, Jones DM, Avram D. Diverting T helper cell trafficking through increased plasticity attenuates autoimmune encephalomyelitis. J Clin Invest 124(1):174-87, 2014. PMID: 24316973.